Search - tctmd.com

Displaying 221 - 240 of 248

Sort: Relevancy | Date

News Daily News

No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients

Todd Neale

January 21, 2020

News Daily News

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Michael O'Riordan

January 21, 2020

News Industry News

Robocath Successfully Completes First Robotic Coronary Angioplasties In Germany With R-One™

January 21, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Daily News

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Michael O'Riordan

January 16, 2020

News Daily News

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

Michael O'Riordan

January 14, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

Michael O'Riordan

January 10, 2020

News Daily News

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Michael O'Riordan

January 08, 2020

News Daily News

Stiff Legs, Compliant Arteries: How Marathon Training Helps the Heart

Michael O'Riordan

January 07, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

Podcast TCTMD Talking Points

REDUCE-FMR: Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation

January 01, 2020

Video

» Interview

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

October 18, 2020

Video

» Interview

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

October 18, 2020

Video

» Interview

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

October 17, 2020

Video

» Interview

TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization

October 16, 2020

Video

» Interview

SCOPE II: A Randomized Trial of Two Self-expanding TAVR Bioprostheses

October 16, 2020

Video

» Interview

MITHRAS: A Randomized Trial of ASD Closure After TMVR

October 16, 2020

Advertisement

No Stroke Reduction but Increased Bleeding With OAC in Dialysis Patients

Most Clinical Trial Sponsors Fail to Report Data as Mandated by FDA

Robocath Successfully Completes First Robotic Coronary Angioplasties In Germany With R-One™

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Pricey, Unproven ‘Executive’ CVD Screening the Norm at Top US Hospitals

Lp(a) Reduction Contributes to Alirocumab’s Treatment Benefit: ODYSSEY Outcomes

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

New AUC for Cardiac Imaging Follow-up in Congenital Heart Disease

EACTS Offers to Help to Resolve EXCEL Controversy, as CRF Launches Review

Stiff Legs, Compliant Arteries: How Marathon Training Helps the Heart

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

REDUCE-FMR: Percutaneous Mitral Annuloplasty in Functional Mitral Regurgitation

TANGO: A Randomized Dose-Escalation Trial of Temsirolimus Adventitial Delivery to Improve Below the Knee Outcomes

OPTIMIZE: A Randomized Trial of a Novel, Ultra Low Profile Fixed-Wire DES

COBRA-REDUCE: A Randomized Trial of a Thromboresistant Polyzene F-Coated Stent With 14 Days DAPT in High-Bleeding Risk Patients

TARGET FFR: A Randomized Trial of Physiology-Guided PCI Optimization

SCOPE II: A Randomized Trial of Two Self-expanding TAVR Bioprostheses

MITHRAS: A Randomized Trial of ASD Closure After TMVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content